NO984564L - FremgangsmÕte for behandling av hjertesvikt med endothelinantagonister - Google Patents

FremgangsmÕte for behandling av hjertesvikt med endothelinantagonister

Info

Publication number: NO984564L
Authority: NO; Norway
Prior art keywords: heart failure; treating heart; endothelin antagonists; blooded animal; warm blooded
Prior art date: 1996-04-04

Application number

NO984564A

Other languages

English (en)

Other versions

NO984564D0 (no

Inventor

Jr Joseph J Lynch

You-Tang Shen

Original Assignee

Banyu Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-04-04

Filing date

1998-09-30

Publication date

1998-12-04

1998-09-30 Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd

1998-09-30 Publication of NO984564D0 publication Critical patent/NO984564D0/no

1998-12-04 Publication of NO984564L publication Critical patent/NO984564L/no

Links

206010019280 Heart failures Diseases 0.000 title abstract 2
102000002045 Endothelin Human genes 0.000 title 1
108050009340 Endothelin Proteins 0.000 title 1
239000005557 antagonist Substances 0.000 title 1
ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 title 1
208000009982 Ventricular Dysfunction Diseases 0.000 abstract 1
239000002308 endothelin receptor antagonist Substances 0.000 abstract 1
230000006815 ventricular dysfunction Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)
Materials For Photolithography (AREA)
Photosensitive Polymer And Photoresist Processing (AREA)

NO984564A 1996-04-04 1998-09-30 FremgangsmÕte for behandling av hjertesvikt med endothelinantagonister NO984564L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US1488296P	1996-04-04	1996-04-04
PCT/US1997/003737 WO1997037665A1 (en)	1996-04-04	1997-03-19	Method of treating heart failure with endothelin antagonists

Publications (2)

Publication Number	Publication Date
NO984564D0 NO984564D0 (no)	1998-09-30
NO984564L true NO984564L (no)	1998-12-04

Family

ID=21768326

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO984564A NO984564L (no)	1996-04-04	1998-09-30	FremgangsmÕte for behandling av hjertesvikt med endothelinantagonister

Country Status (25)

Country	Link
US (3)	US5834483A (no)
EP (1)	EP0906108B1 (no)
JP (2)	JP3345891B2 (no)
KR (1)	KR20000005178A (no)
CN (1)	CN1215335A (no)
AT (1)	ATE297739T1 (no)
AU (1)	AU723351B2 (no)
BG (1)	BG102716A (no)
BR (1)	BR9708525A (no)
CA (1)	CA2249330C (no)
CZ (1)	CZ296098A3 (no)
DE (1)	DE69733557T2 (no)
EA (1)	EA003587B1 (no)
EE (1)	EE9800315A (no)
ES (1)	ES2241047T3 (no)
HU (1)	HUP9903893A3 (no)
IL (1)	IL126175A (no)
IS (1)	IS4847A (no)
NO (1)	NO984564L (no)
NZ (1)	NZ331789A (no)
PL (1)	PL329077A1 (no)
SK (1)	SK130098A3 (no)
TR (1)	TR199801988T2 (no)
UA (1)	UA50761C2 (no)
WO (1)	WO1997037665A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2249330C (en)	1996-04-04	2005-08-09	Banyu Pharmaceutical Co., Ltd.	Method of treating heart failure with endothelin antagonists
JPH11514676A (ja) *	1996-08-09	1999-12-14	メルクエンドカンパニーインコーポレーテッド	立体選択的脱酸素化反応
AU742423B2 (en)	1998-01-21	2002-01-03	Msd K.K.	Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative
US8168616B1 (en)	2000-11-17	2012-05-01	Novartis Ag	Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
WO2004060885A1 (ja) *	2002-12-27	2004-07-22	Kaneka Corporation	光学活性２−チオメチル−３−フェニルプロピオン酸誘導体およびその合成中間体の製造法
KR20120008093A (ko)	2003-11-17	2012-01-25	노파르티스 아게	디펩티딜 펩티다제 ⅳ 억제제의 용도
GB0327839D0 (en)	2003-12-01	2003-12-31	Novartis Ag	Organic compounds
NZ586285A (en)	2004-03-17	2011-12-22	Novartis Ag	Use of aliskiren in monotherapy for treating diabetes and metabolic disorder (syndrome X)
JP4967136B2 (ja)	2005-06-24	2012-07-04	国立大学法人東京医科歯科大学	薬剤溶出性ステント
TW201136582A (en)	2010-03-16	2011-11-01	Novartis Ag	Improved pharmaceutical compositions of aliskiren and methods of delivery

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4971959A (en) *	1987-04-14	1990-11-20	Warner-Lambert Company	Trisubstituted phenyl analogs having activity for congestive heart failure
GB9007762D0 (en) *	1990-04-05	1990-06-06	Beecham Group Plc	Novel compounds
US5565485A (en) *	1993-03-19	1996-10-15	Merck & Co., Inc.	Biphenyl compounds useful or endothelin antagonists
NZ266314A (en)	1993-04-27	1998-10-28	Smithkline Beecham Corp	Various indane-2-carboxylic acid derivatives substituted by (hetero)aryl-containing moieties and various other indane derivatives as endothelian receptor antagonists and pharmaceutical compositions
US5571813A (en) *	1993-06-10	1996-11-05	Beiersdorf-Lilly Gmbh	Fused pyrimidine compounds and their use as pharmaceuticals
US5389620A (en) *	1993-08-18	1995-02-14	Banyu Pharmaceutical Co., Ltd.	Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives
DK0714897T3 (da) *	1993-08-18	2001-03-19	Banyu Pharma Co Ltd	Ring-kondenseret heteroaromatisk cyclopentenderivat med endothelinantagonist-aktivitet
US5658943A (en) *	1995-01-05	1997-08-19	Warner-Lambert Company	Phenylalanine derivatives as endothelin antagonists
CA2249330C (en) *	1996-04-04	2005-08-09	Banyu Pharmaceutical Co., Ltd.	Method of treating heart failure with endothelin antagonists

1997
- 1997-03-19 CA CA002249330A patent/CA2249330C/en not_active Expired - Fee Related
- 1997-03-19 WO PCT/US1997/003737 patent/WO1997037665A1/en not_active Ceased
- 1997-03-19 JP JP53619497A patent/JP3345891B2/ja not_active Expired - Fee Related
- 1997-03-19 NZ NZ331789A patent/NZ331789A/xx unknown
- 1997-03-19 UA UA98105222A patent/UA50761C2/uk unknown
- 1997-03-19 HU HU9903893A patent/HUP9903893A3/hu unknown
- 1997-03-19 EP EP97914955A patent/EP0906108B1/en not_active Expired - Lifetime
- 1997-03-19 IL IL12617597A patent/IL126175A/xx not_active IP Right Cessation
- 1997-03-19 AU AU22025/97A patent/AU723351B2/en not_active Ceased
- 1997-03-19 PL PL97329077A patent/PL329077A1/xx unknown
- 1997-03-19 TR TR1998/01988T patent/TR199801988T2/xx unknown
- 1997-03-19 ES ES97914955T patent/ES2241047T3/es not_active Expired - Lifetime
- 1997-03-19 DE DE69733557T patent/DE69733557T2/de not_active Expired - Lifetime
- 1997-03-19 KR KR1019980707850A patent/KR20000005178A/ko not_active Ceased
- 1997-03-19 EE EE9800315A patent/EE9800315A/xx unknown
- 1997-03-19 SK SK1300-98A patent/SK130098A3/sk unknown
- 1997-03-19 CZ CZ982960A patent/CZ296098A3/cs unknown
- 1997-03-19 CN CN97193645A patent/CN1215335A/zh active Pending
- 1997-03-19 EA EA199800889A patent/EA003587B1/ru not_active IP Right Cessation
- 1997-03-19 AT AT97914955T patent/ATE297739T1/de not_active IP Right Cessation
- 1997-03-19 BR BR9708525A patent/BR9708525A/pt not_active Application Discontinuation
- 1997-03-26 US US08/824,848 patent/US5834483A/en not_active Expired - Fee Related
1998
- 1998-08-11 US US09/132,514 patent/US6087360A/en not_active Expired - Lifetime
- 1998-08-21 BG BG102716A patent/BG102716A/xx unknown
- 1998-09-15 IS IS4847A patent/IS4847A/is unknown
- 1998-09-30 NO NO984564A patent/NO984564L/no not_active Application Discontinuation
2000
- 2000-02-22 US US09/507,666 patent/US6380195B1/en not_active Expired - Fee Related
2001
- 2001-12-07 JP JP2001374870A patent/JP2002220337A/ja active Pending

Also Published As

Publication number	Publication date
BG102716A (en)	1999-09-30
CA2249330C (en)	2005-08-09
EP0906108A1 (en)	1999-04-07
ES2241047T3 (es)	2005-10-16
CA2249330A1 (en)	1997-10-16
DE69733557D1 (de)	2005-07-21
NO984564D0 (no)	1998-09-30
AU2202597A (en)	1997-10-29
UA50761C2 (uk)	2002-11-15
PL329077A1 (en)	1999-03-15
DE69733557T2 (de)	2005-11-03
JP2000510824A (ja)	2000-08-22
SK130098A3 (en)	1999-05-07
EE9800315A (et)	1999-06-15
EP0906108B1 (en)	2005-06-15
AU723351B2 (en)	2000-08-24
NZ331789A (en)	2000-05-26
EA199800889A1 (ru)	1999-04-29
CN1215335A (zh)	1999-04-28
JP3345891B2 (ja)	2002-11-18
EP0906108A4 (en)	2000-12-06
WO1997037665A1 (en)	1997-10-16
IL126175A (en)	2003-05-29
KR20000005178A (ko)	2000-01-25
ATE297739T1 (de)	2005-07-15
IS4847A (is)	1998-09-15
HUP9903893A3 (en)	2001-05-28
US6380195B1 (en)	2002-04-30
TR199801988T2 (xx)	2000-08-21
US6087360A (en)	2000-07-11
IL126175A0 (en)	1999-05-09
US5834483A (en)	1998-11-10
EA003587B1 (ru)	2003-06-26
JP2002220337A (ja)	2002-08-09
CZ296098A3 (cs)	1999-06-16
BR9708525A (pt)	1999-08-03
HUP9903893A2 (hu)	2001-04-28

Publication	Publication Date	Title
CY1110282T1 (el)	2015-01-14	Ενωσεις για την αγωγη της απωλειας βαρους
IL130083A0 (en)	2000-02-29	3-Pyridyl enantiomers and their use as analgesics
CY1109191T1 (el)	2014-07-02	Μια νεα χρηση της δεφεριπρονης
DE69928226D1 (de)	2005-12-15	Chemokin rezeptor antagonisten und verwndung
EA200200194A1 (ru)	2002-08-29	Антагонисты хемокинного рецептора и способы их применения
NO984564L (no)	1998-12-04	FremgangsmÕte for behandling av hjertesvikt med endothelinantagonister
DE69617729D1 (de)	2002-01-17	Verwendung von antimineralcorticoidverbindungen gegen das drogenentzugssyndrom
EA200100716A1 (ru)	2002-06-27	Способ профилактики рака молочной железы
NO20003313D0 (no)	2000-06-23	Terapeutiske midler
WO2000048446A3 (en)	2001-02-08	Use of antagonists of pg-e for the treatment of neuropathic pain
ATE242641T1 (de)	2003-06-15	Behandlung von stressinduzierten hautkrankheiten unter verwendung von corticoliberin (crh)- antagonisten und inhibitoren der hautmastzell- degranulation
MY126321A (en)	2006-09-29	Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
ATE289506T1 (de)	2005-03-15	Hemmung der tnf-aktivität mit zusammensetzungen enthaltend heparin und lösliche tnf rezeptoren
DK0862454T3 (da)	2002-12-30	CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
ATE268170T1 (de)	2004-06-15	Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz
AR008155A1 (es)	1999-12-09	Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.
EA200101159A1 (ru)	2002-06-27	Произодное аминотетралина для терапии сердечно-сосудистых заболеваний

Legal Events

Date	Code	Title	Description
2004-12-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application